• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100蛋白亚型在恶性黑色素瘤以及良性和恶性周围神经鞘瘤中的差异表达。

Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.

作者信息

Nonaka Daisuke, Chiriboga Luis, Rubin Brian P

机构信息

Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.

出版信息

J Cutan Pathol. 2008 Nov;35(11):1014-9. doi: 10.1111/j.1600-0560.2007.00953.x. Epub 2008 Jun 10.

DOI:10.1111/j.1600-0560.2007.00953.x
PMID:18547346
Abstract

BACKGROUND

Desmoplastic melanoma (DM) may simulate various benign and malignant lesions, including benign peripheral nerve sheath tumors (BPNSTs) and malignant peripheral nerve sheath tumors (MPNSTs). The latter case is diagnostically challenging because DM generally show only S100 protein expression but no reaction to melanocytic markers. S100 family of proteins consists of over 20 members. We report on S100 subtypes in malignant melanomas (MMs), and BPNSTs and MPNSTs to investigate differential expression.

DESIGN

S100A1, S100A2, S100A4, S100A6 and S100B immunostains were performed on 80 MMs including conventional and desmoplastic types, 86 BPNSTs and 77 MPNSTs.

RESULTS

S100A1 expression was seen in > 91% of MMs in a diffuse reaction, whereas BPNSTs showed focal or no reaction. Sixteen percent of MPNSTs focally expressed S100A1 except for one case with diffuse reaction. S100A2 staining was negative or focal in all three groups whereas S100A4 reaction was variable in all three. S100A6 was diffusely expressed in MMs, BPNSTs and MPNSTs. S100B was stained diffusely in MMs and BPNSTs, but its reaction was observed in 30% of MPNSTs in a focal fashion.

CONCLUSION

S100A1 expression was diffuse in most of MMs but absent or focal in BPNSTs and MPNSTs. This may be helpful to distinguish between the two entities.

摘要

背景

促纤维增生性黑色素瘤(DM)可能会模拟各种良性和恶性病变,包括良性外周神经鞘瘤(BPNST)和恶性外周神经鞘瘤(MPNST)。后一种情况在诊断上具有挑战性,因为DM通常仅显示S100蛋白表达,而对黑素细胞标记物无反应。S100蛋白家族由20多个成员组成。我们报告恶性黑色素瘤(MM)、BPNST和MPNST中的S100亚型,以研究差异表达。

设计

对80例MM(包括传统型和促纤维增生型)、86例BPNST和77例MPNST进行S100A1、S100A2、S100A4、S100A6和S100B免疫染色。

结果

超过91%的MM可见弥漫性S100A1表达,而BPNST显示局灶性反应或无反应。除1例弥漫性反应外,16%的MPNST局灶性表达S100A1。三组中S100A2染色均为阴性或局灶性,而三组中S100A4反应各不相同。S100A6在MM、BPNST和MPNST中均弥漫性表达。S100B在MM和BPNST中弥漫性染色,但在30%的MPNST中呈局灶性反应。

结论

S100A​​1在大多数MM中呈弥漫性表达,但在BPNST和MPNST中缺失或呈局灶性表达。这可能有助于区分这两种实体。

相似文献

1
Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.S100蛋白亚型在恶性黑色素瘤以及良性和恶性周围神经鞘瘤中的差异表达。
J Cutan Pathol. 2008 Nov;35(11):1014-9. doi: 10.1111/j.1600-0560.2007.00953.x. Epub 2008 Jun 10.
2
Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.Podoplanin表达在周围神经鞘瘤中的诊断意义。
Am J Clin Pathol. 2008 Jun;129(6):886-93. doi: 10.1309/M7D5KTVYYE51XYQA.
3
Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.钙结合蛋白S100在正常人体皮肤和黑素细胞病变中的免疫组化定位
Br J Dermatol. 1997 Jul;137(1):39-43.
4
Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.利用组织芯片检测S100A6蛋白在多种皮肤肿瘤中的表达
J Cutan Pathol. 2008 Nov;35 Suppl 2:28-34. doi: 10.1111/j.1600-0560.2007.00866.x. Epub 2008 Jan 14.
5
S100A6 protein expression is different in Spitz nevi and melanomas.S100A6蛋白表达在Spitz痣和黑色素瘤中存在差异。
Mod Pathol. 2003 May;16(5):505-11. doi: 10.1097/01.MP.0000071128.67149.FD.
6
P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.P75 神经生长因子受体染色在识别梭形细胞和促结缔组织增生性黑色素瘤方面优于 S100。
J Am Acad Dermatol. 2010 Nov;63(5):852-8. doi: 10.1016/j.jaad.2009.11.688.
7
Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.肌动蛋白在神经嵴细胞衍生肿瘤中的表达,包括神经鞘瘤、恶性外周神经鞘膜瘤、神经纤维瘤和黑素细胞肿瘤。
Pathol Int. 2009 Feb;59(2):86-90. doi: 10.1111/j.1440-1827.2008.02333.x.
8
Sox10: a pan-schwannian and melanocytic marker.Sox10:一种泛施万细胞和黑素细胞标志物。
Am J Surg Pathol. 2008 Sep;32(9):1291-8. doi: 10.1097/PAS.0b013e3181658c14.
9
Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.Sox10 在各种组织学的原发性黑色素细胞肿瘤中表达,但不在纤维组织细胞增生和组织细胞增多症中表达。
J Am Acad Dermatol. 2012 Oct;67(4):717-26. doi: 10.1016/j.jaad.2011.12.035. Epub 2012 Feb 9.
10
Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas.犬外周神经鞘瘤及其他软组织肉瘤的免疫组织化学评估
Vet Pathol. 2004 Jul;41(4):307-18. doi: 10.1354/vp.41-4-307.

引用本文的文献

1
Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.颅脊柱轴恶性外周神经鞘瘤的外科治疗:单机构经验和文献复习。
World J Surg Oncol. 2023 Oct 26;21(1):338. doi: 10.1186/s12957-023-03227-y.
2
Identification of TUBB4A as a Prognostic Biomarker of Melanoma by Transcriptomic Data and Experiments.通过转录组数据和实验鉴定 TUBB4A 作为黑色素瘤的预后生物标志物。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231184842. doi: 10.1177/15330338231184842.
3
Imaging Mass Spectrometry for the Classification of Melanoma Based on / Mutational Status.
基于 / 突变状态的黑色素瘤分类的成像质谱分析。
Int J Mol Sci. 2023 Mar 7;24(6):5110. doi: 10.3390/ijms24065110.
4
The Importance of Immunohistochemistry in the Evaluation of Tumor Depth of Primary Cutaneous Melanoma.免疫组织化学在原发性皮肤黑色素瘤肿瘤深度评估中的重要性。
Diagnostics (Basel). 2023 Mar 7;13(6):1020. doi: 10.3390/diagnostics13061020.
5
Ultrasound Examination Facilitated the Diagnosis of an Intercostal Schwannoma.超声检查有助于诊断肋间神经鞘瘤。
Cureus. 2022 Jun 19;14(6):e26079. doi: 10.7759/cureus.26079. eCollection 2022 Jun.
6
Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis.皮肤黑色素瘤:应用免疫组织化学诊断的单中心经验。
Int J Mol Sci. 2022 May 25;23(11):5911. doi: 10.3390/ijms23115911.
7
Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma.黑色素瘤诊断、预后及免疫治疗反应的生物标志物
Cancers (Basel). 2021 Jun 9;13(12):2875. doi: 10.3390/cancers13122875.
8
Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.表面活性剂辅助的无标记单细胞蛋白质组学的一锅法样品制备。
Commun Biol. 2021 Mar 1;4(1):265. doi: 10.1038/s42003-021-01797-9.
9
Diagnostic and Prognostic Biomarkers for Myocardial Infarction.心肌梗死的诊断和预后生物标志物
Front Cardiovasc Med. 2021 Feb 3;7:617277. doi: 10.3389/fcvm.2020.617277. eCollection 2020.
10
Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities.黑色素瘤生物标志物及其在体内诊断成像模式中的潜在应用。
Int J Mol Sci. 2020 Dec 16;21(24):9583. doi: 10.3390/ijms21249583.